Ngokuqhelekileyo, ekwonyango kwesibindi kunye ne-gall bladder pathologies, iziyobisi ze-hepatoprotective ezisekelwe kwi-bile ursodeoxycholic acid zisetyenziswa njengenxalenye yonyango olunzima. Ezi zonyango ziquka izifaniso zase-Urdoks ne-Ursosan, oogqirha abanokumisela kwisigulane esikhethweyo (kunye nezinye izidakamizwa ezifanayo zinokucetyiswa kwakhona). Izigulane ezininzi, ukuya kwi-pharmacy, zibuzwa into engcono - i-Urdoksa okanye i-Ursosan, kwaye zeziphi iziyobisi ezithandayo. Makhe siqwalasele, ukuba ngaba kukho ukungafani kumalungiselelo anikezelweyo, kwaye siya kuqhelana ngakumbi ngeenkcukacha zabo.
Ukufana kunye nokwahlukana kwezidakamizwa i-Urdoksa ne-Ursosan
Bobabini i-Urdoksa ne-Ursosan ziyafumaneka ngeefomsile eziboshwe nge-gelatin. Umxholo we-active substance (i-ursodeoxycholic acid) nayo iyafana kwaye i-250 mg. Ukubunjwa kwe-Urdoksa kunye ne-Ursosan akufani nento malunga neenxalenye zenkxaso, uludwe lwayo lulo lulandelayo:
- isitashi;
- i-silicon dioxide colloidal;
- i-magnesium stearate.
Oko kunjalo, e-Urdoksa nase-Ursosan - into efanayo.
Ukwahluke phakathi kwezi zi yobisi kubakho abavelisi, kunye neendleko ezidibeneyo. I-Ursosan ikhiqizwa yinkampani yaseCzech, kwaye umenzi wase-Urdoksa yiRashiya. Ixabiso leziyobisi zasekhaya lincinci. Kufuneka kuqatshelwe ukuba zonke izithako ezifunekayo zase-Urdoksi zithengwa ngaphandle, ngoko ke zinempawu ezifanayo kunye ne-Ursosan (umzekelo, kwinqanaba lokuhlanjululwa kweemveliso zamakhemikhali).
Impembelelo yokwelapha yase-Urdoksy ne-Ursosana
Isenzo samachiza sezilwanyana zombini sichazwa yimpembelelo yesithako esisebenzayo, esithi emva kokuhlanganiswa kwiiseli ze-hepatocytes, sinefuthe elilandelayo:
- ukuxothwa kwe-acid acids;
- kuncipha kwi-bile ye-bile ne-cholesterol;
- ukuqheleka kwe-bile ehamba kwi-duodenum;
- ukuchithwa kwamatye e-cholesterol kwi-gallbladder kunye nokuthintela ukubunjwa kwezinto ezintsha;
- isenzo se-cytoprotective;
- Ukubuyiselwa kwesakhiwo se membrane isakhiwo se-hepatocytes;
- umphumo wokuchasa;
- ukwandisa umphumo we-anti-antial agents;
- ukuvimbela ukuphuhliswa kwezicubu ezinxulumene nesibindi;
- ukunyusa umzimba.
Njengomphumo wokuthatha le mali, ubunzima be-asthenic syndrome uphawu lwesifo sesibindi, kunye ne-dyspepsia, ukutshaya kwesikhumba, kuncitshiswa kakhulu. Kukho ukukhawuleza ngokukhawuleza ekukhululeni ubungakanani besibindi, ukusetyenziswa kwe-synthesis kunye ne-excretion ye-bile.
Iimpawu zokusebenzisa i-Urdoksy ne-Ursosana:
- i- cholelithiasis engazinzanga ;
- i-hepatitis engapheliyo yeentlobo ezahlukeneyo zendalo;
- i-cirrhosis yebhiliyali ephambili;
- cystic fibrosis;
- isifo sesibindi sesibindi;
- non-alcoholic steatohepatitis;
- i-dyskinesia ye-bile ducts, njl.
Isilinganisi seziyobisi, kunye nexesha lolawulo kunye nobude bokusetyenziswa lihluka ngoxhomekeke kwi-diagnostic, iimpawu zomzimba ngamnye kunye nobunzima beenkqubo ze-pathological process. Ngokomyinge, i-dose yemihla ngemihla ye-ursodeoxycholic acid ukwenzela unyango kunye nokukhusela yi-capsules 2-3, kwaye ubude bekhosi yonyango lunokuba
Ukungqinelana kokwamkela i-Urdoksy ne-Ursosana:
- i-hypersensitive to the components of the drug;
- i-gallstones ephezulu kwi-calcium;
- i-gallbladder engasebenzi;
- ukuphazamiseka okuphawulekayo komsebenzi wempuphu, umsebenzi we-hepatic okanye we-pancreatic;
- i-cirrhosis yesibindi kwisigaba sokuhlawula;
- izifo ezinokusuleleka kunye nokuvuvukala kwephepha lebhiliyari, njl.